Natural Products Counteracting Cardiotoxicity during Cancer Chemotherapy: The Special Case of Doxorubicin, a Comprehensive Review.
Izabela Koss-MikołajczykVanja TodorovicSladjana SobajicJamal MahajnaMarko GerićJosep Antonio TurAgnieszka BartoszekPublished in: International journal of molecular sciences (2021)
Cardiotoxicity is a frequent undesirable phenomenon observed during oncological treatment that limits the therapeutic dose of antitumor drugs and thus may decrease the effectiveness of cancer eradication. Almost all antitumor drugs exhibit toxic properties towards cardiac muscle. One of the underlying causes of cardiotoxicity is the stimulation of oxidative stress by chemotherapy. This suggests that an appropriately designed diet or dietary supplements based on edible plants rich in antioxidants could decrease the toxicity of antitumor drugs and diminish the risk of cardiac failure. This comprehensive review compares the cardioprotective efficacy of edible plant extracts and foodborne phytochemicals whose beneficial activity was demonstrated in various models in vivo and in vitro. The studies selected for this review concentrated on a therapy frequently applied in cancer, anthracycline antibiotic-doxorubicin-as the oxidative stress- and cardiotoxicity-inducing agent.
Keyphrases
- oxidative stress
- papillary thyroid
- squamous cell
- left ventricular
- randomized controlled trial
- drug delivery
- dna damage
- physical activity
- lymph node metastasis
- prostate cancer
- locally advanced
- heart failure
- induced apoptosis
- radiation therapy
- ischemia reperfusion injury
- young adults
- helicobacter pylori infection
- bone marrow
- rectal cancer
- mesenchymal stem cells
- diabetic rats
- endoplasmic reticulum stress
- cell therapy
- smoking cessation
- plant growth